You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database

Article info

Article menu

Download PDFPDF

XML
Pharmacology and therapeutics
Original research
Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database

Authors

  • Amelia Smith Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, University of Dublin Trinity College, Dublin, IrelandMedicines Management Programme, Health Service Executive, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Michael Barry Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, University of Dublin Trinity College, Dublin, IrelandMedicines Management Programme, Health Service Executive, Dublin, IrelandNational Centre for Pharmacoeconomics, St. James’s Hospital, Dublin, Ireland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amelia Smith; smitha25{at}tcd.ie
View Full Text

Citation

Smith A, Barry M
Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
BMJ Open 2020;10:e040806. doi: 10.1136/bmjopen-2020-040806

Publication history

  • Received May 22, 2020
  • Revised October 19, 2020
  • Accepted October 20, 2020
  • First published November 14, 2020.
Online issue publication 
October 18, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.